An example of a product roadmap for a Series B startup in the healthcare industry must organize initiatives around four tracks that do not exist in standard SaaS roadmaps: the clinical evidence track (building the outcome data that justifies payor reimbursement), the regulatory track (FDA clearance, HIPAA, SOC 2, state-specific requirements), the EHR integration track (the interoperability that enterprise health system customers require), and the payor strategy track (the path from out-of-pocket to insurance reimbursement).
A Series B healthcare startup that creates a standard three-horizon product roadmap will have the right format but the wrong content. The clinical evidence, regulatory, and payor tracks are not features — they are the infrastructure that determines whether the product can be sold to the enterprise health system segment at all.
The Four-Track Healthcare Series B Roadmap
Track 1: Clinical Evidence (Build the proof that justifies reimbursement)
Why this track is first: Health systems and payors require peer-reviewed or health-economic evidence before making coverage decisions. Building clinical evidence takes 12–18 months minimum, which means it must start at Series B to be ready for Series C payor conversations.
Series B clinical evidence initiatives:
- Partner with 2–3 academic medical centers for a retrospective outcome study (12-month window)
- Instrument the product to generate HEDIS-compatible outcome metrics (required for most payor conversations)
- Publish a white paper with IRB-approved pilot data from your Series A deployments
- Design and begin enrollment for a prospective randomized controlled trial (18–24 month timeline)
Clinical evidence track OKRs:
- Outcome: One peer-reviewed publication or white paper by Q3 of year 1
- Outcome: HEDIS-compatible metrics available in product analytics by Q2
Track 2: Regulatory (Compliance as a competitive moat)
Series B regulatory priorities:
- SOC 2 Type II certification (required for all health system sales)
- HIPAA technical safeguards audit and remediation
- FDA Software as a Medical Device (SaMD) classification review (if product makes clinical decisions or recommendations)
- State-specific telehealth and digital health regulations for target expansion states
According to Lenny Rachitsky's writing on healthtech product strategy, the healthcare startups that scale fastest are those that complete SOC 2 Type II and HIPAA remediation by the end of Series B — these certifications open the enterprise health system segment without which most healthcare Series B products plateau at mid-market clinic adoption.
Track 3: EHR Integration (Interoperability as a switching cost)
Target EHR integrations by market presence:
- Epic (60% of health system market) — SMART on FHIR integration
- Oracle Health (formerly Cerner) — CCD/CCDA integration
- athenahealth (independent practices) — API integration
- Integration layer: HL7 FHIR R4 as the standard data exchange protocol
EHR integration sequencing:
- Q1: Epic SMART on FHIR app submission and certification (12-week review process)
- Q2: HL7 FHIR R4 data exchange for all supported data types
- Q3: Oracle Health integration for expansion accounts
- Q4: USCDI v3 compliance for federal program eligibility
Track 4: Payor Strategy (The path to sustainable economics)
Series B payor track milestones:
- Q1: Identify 2–3 target Medicare Advantage plans for pilot conversations
- Q2: Present value-based care pilot proposal to target payors
- Q3: Execute value-based care pilot agreement with at least one payor
- Q4: Generate claims data analysis showing cost avoidance from product use
According to Shreyas Doshi on Lenny's Podcast, in healthcare the payor track is the most underinvested dimension of a Series B product roadmap — teams focus entirely on health system adoption and ignore that sustainable economics in healthcare often require insurance reimbursement, not just provider contracts.
Roadmap Format
Q1 2026 Q2 2026 Q3 2026 Q4 2026
─────────────────────────────────────────────────────────────
TRACK 1: CLINICAL EVIDENCE
Retrospective study ████████████
HEDIS metrics ████████
White paper ████████████
RCT enrollment ████████████
TRACK 2: REGULATORY
SOC 2 Type II ████████████████
HIPAA audit ████████
FDA SaMD review ████████████
TRACK 3: EHR INTEGRATION
Epic FHIR certification ████████████
HL7 FHIR R4 ████████████
Oracle Health ████████████
TRACK 4: PAYOR STRATEGY
MA plan identification ████
VBC pilot proposal ████████
Pilot agreement ████████
FAQ
Q: What should a Series B healthcare startup product roadmap include? A: Four tracks specific to healthcare: clinical evidence building (outcome data for payor conversations), regulatory compliance (SOC 2, HIPAA, FDA), EHR integration (Epic FHIR, HL7 interoperability), and payor strategy (value-based care pilot path).
Q: Why is clinical evidence a product roadmap track for a healthcare startup? A: Health systems and payors require peer-reviewed or health-economic evidence before making coverage decisions. Clinical evidence takes 12-18 months to generate, which means it must start at Series B to support Series C payor and enterprise sales conversations.
Q: What EHR integrations should a Series B healthcare startup prioritize? A: Epic SMART on FHIR first (60% of health system market), then HL7 FHIR R4 as the standard protocol layer, then Oracle Health (formerly Cerner) for expansion accounts.
Q: When should a healthcare startup start payor strategy conversations? A: At Series B, beginning with Medicare Advantage plans which have more flexible value-based care pilot programs than traditional commercial insurance. Payor conversations that start at Series C are typically 2 years too late.
Q: What is the most common Series B healthcare startup roadmap mistake? A: Treating compliance, clinical evidence, and EHR integration as support costs rather than strategic roadmap tracks. These investments determine access to the enterprise health system and payor segments that define the Series C fundraising story.
HowTo: Create a Product Roadmap for a Series B Healthcare Startup
- Define four tracks alongside your standard product tracks: clinical evidence, regulatory compliance, EHR integration, and payor strategy
- Start clinical evidence investments (retrospective study, HEDIS metric instrumentation) in Q1 of year 1 since they require 12 to 18 months to produce publishable results
- Prioritize SOC 2 Type II and Epic FHIR certification as the two compliance investments that unlock the enterprise health system segment
- Begin payor strategy conversations with 2 to 3 Medicare Advantage plans at Series B since payor conversations take 12 to 24 months to convert to pilot agreements
- Report all four tracks to the board quarterly with separate OKRs for each, positioning them as strategic moat-building investments rather than overhead